Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase

被引：13

作者：

Selness, Shaun R. ^{[1
]}

Boehm, Terri L. ^{[1
]}

Walker, John K. ^{[1
]}

Devadas, Balekudru ^{[1
]}

Durley, Richard C. ^{[1
]}

Kurumbail, Ravi ^{[2
]}

Shieh, Huey ^{[2
]}

Xing, Li ^{[2
]}

Hepperle, Michael ^{[1
]}

Rucker, Paul V. ^{[1
]}

Jerome, Kevin D. ^{[1
]}

Benson, Alan G. ^{[1
]}

Marrufo, Laura D. ^{[1
]}

Madsen, Heather M. ^{[1
]}

Hitchcock, Jeff ^{[1
]}

Owen, Tom J. ^{[1
]}

Christie, Lance ^{[1
]}

Promo, Michele A. ^{[1
]}

Hickory, Brian S. ^{[1
]}

Alvira, Edgardo ^{[1
]}

Naing, Win ^{[1
]}

Blevis-Bal, Radhika ^{[1
]}

Devraj, Rajesh V. ^{[1
]}

Messing, Dean ^{[3
]}

Schindler, John F. ^{[4
]}

Hirsch, Jeffrey ^{[4
]}

Saabye, Matthew ^{[4
]}

Bonar, Sheri ^{[4
]}

Webb, Elizabeth ^{[4
]}

Anderson, Gary ^{[4
]}

Monahan, Joseph B. ^{[2
,4
]}

机构：

[1] Pfizer Corp, Dept Med Chem, Chesterfield, MO 63017 USA

[2] Pfizer Corp, Struct & Computat Chem, Chesterfield, MO 63017 USA

[3] Pfizer Corp, Dept Pharmcokinet & Drug Metab, Chesterfield, MO 63017 USA

[4] Pfizer Corp, Inflammat Biol, Chesterfield, MO 63017 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 13期

关键词：

p38; kinase; Inflammation; Rheumatoid arthritis; TNF alpha; Pyridinones; RHEUMATOID-ARTHRITIS;

D O I：

10.1016/j.bmcl.2011.04.120

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of N-aryl pyridinone inhibitors of p38 mitogen activated protein (MAP) kinase were designed and prepared based on the screening hit SC-25028 (1) and structural comparisons to VX-745 (5). The focus of the investigation targeted the dependence of potency and metabolic stability on the benzyloxy connectivity, the role of the C-6 position and the substitution pattern on the N-phenyl ring. Further optimization produced the highly selective and potent pyridinones 2 and 3. These inhibitors exhibited activity in both acute and chronic models of inflammation. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：4059 / 4065

页数：7

共 50 条

[21] Discovery of Pyridazinopyridinones as Potent and Selective p38 Mitogen-Activated Protein Kinase Inhibitors
Wu, Bin
Wang, Hui-Ling
Pettus, Liping
Wurz, Ryan P.
Doherty, Elizabeth M.
Henkle, Bradley.
McBride, Helen J.
Saris, Christiaan J. M.
Wong, Lu Min
Plant, Matthew H.
Sherman, Lisa
Lee, Matthew R.
Hsieh, Faye
Tasker, Andrew S.
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (17) : 6398 - 6411
[22] Aminopyridine N-oxides as potent and orally bioavailable inhibitors of p38 MAP kinase: Design, synthesis, SAR, and in vivo anti-inflammatory activity
Lumeras, Wenceslao
Caturla, Francisco
Vidal, Laura
Esteve, Cristina
Vidal, Bernat
Balague, Cristina
Orellana, Adelina
Godessart, Nuria
Dominguez, Maria
Roca, Ramon
Huerta, Josep M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[23] Design of potent and selective 2-aminobenzimidazole-based p38α MAP kinase inhibitors with excellent in vivo efficacy
de Dios, A
Shih, C
de Uralde, BL
Sánchez, C
Del Prado, M
Cabrejas, LMM
Pleite, S
Blanco-Urgoiti, J
Lorite, MJ
Nevill, CR
Bonjouklian, R
York, J
Vieth, M
Wang, Y
Magnus, N
Campbell, RM
Anderson, BD
McCann, DJ
Giera, DD
Lee, PA
Schultz, RM
Li, LC
Johnson, LM
Wolos, JA
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (07) : 2270 - 2273
[24] AMINOPYRIDINE N-OXIDES AS POTENT, ORALLY BIOAVAILABLE INHIBITORS OF p38 MAP KINASE: DESIGN, SYNTHESIS, SAR AND IN VIVO ANTI-INFLAMMATORY ACTIVITY
Lumeras, Wenceslao
Caturla, Francisco
Vidal, Laura
Esteve, Cristina
Balague, Cristina
Orellana, Adelina
Dominguez, Maria
Roca, Romon
Huerta, Josep M.
Godessart, Nuria
Vidal, Bernat
DRUGS OF THE FUTURE, 2009, 34 : 111 - 111
[25] Synthesis and SAR of 6-(carbocycle)-substituted 2-pyridones as potent and selective p38 kinase inhibitors
Hong, FT
Tadesse, S
Tamayo, N
Liao, L
Goldberg, M
Cao, CQ
Powers, D
Yudor, YY
Yu, V
Wong, M
Henkle, B
Middleton, S
Syed, R
Harvey, T
Hungate, R
Dominguez, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2725 - U2725
[26] Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase
Trejo, A
Arzeno, H
Browner, M
Chanda, S
Cheng, S
Comer, DD
Dalrymple, SA
Dunten, P
Lafargue, J
Lovejoy, B
Freire-Moar, J
Lim, J
Mcintosh, J
Miller, J
Papp, E
Reuter, D
Roberts, R
Sanpablo, F
Saunders, J
Song, K
Villasenor, A
Warren, SD
Welch, M
Weller, P
Whiteley, PE
Zeng, L
Goldstein, DM
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) : 4702 - 4713
[27] Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors
Chen, Meng-Hsin
Fitzgerald, Patricia
Singh, Suresh B.
O'Neill, Edward A.
Schwartz, Cheryl D.
Thompson, Chris M.
O'Keefe, Stephen J.
Zaller, Dennis M.
Doherty, James B.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 2222 - 2226
[28] Design and Synthesis of Highly Selective Brain Penetrant p38α Mitogen-Activated Protein Kinase Inhibitors
Tormaehlen, Niklas M.
Martorelli, Mariella
Kuhn, Annette
Maier, Florian
Guezguez, Jamil
Burnet, Michael
Albrecht, Wolfgang
Laufer, Stefan A.
Koch, Pierre
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (02) : 1225 - 1242
[29] Design, Synthesis, and Structure-Activity Relationships of Aminopyridine N-Oxides, a Novel Scaffold for the Potent and Selective Inhibition of p38 Mitogen Activated Protein Kinase
Lumeras, Wenceslao
Caturla, Francisco
Vidal, Laura
Esteve, Cristina
Balague, Cristina
Orellana, Adelina
Dominguez, Maria
Roca, Ramon
Huerta, Josep M.
Godessart, Nuria
Vidal, Bernat
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (17) : 5531 - 5545
[30] 5-Amino-pyrazoles as potent and selective p38α inhibitors
Das, Jagabandhu
Moquin, Robert V.
Dyckman, Alaric J.
Li, Tianle
Pitt, Sidney
Zhang, Rosemary
Shen, Ding Ren
McIntyre, Kim W.
Gillooly, Kathleen
Doweyko, Arthur M.
Newitt, John A.
Sack, John S.
Zhang, Hongjian
Kiefer, Susan E.
Kish, Kevin
McKinnon, Murray
Barrish, Joel C.
Dodd, John H.
Schieven, Gary L.
Leftheris, Katerina
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 6886 - 6889

← 1 2 3 4 5 →